部落格 · 最新 · 標註日期 · 有據可查
GLP-1，最新動態——2026 年發生了什麼變化，數據說明了什麼。
直接回答今年人們真正在搜尋的問題，每篇文章都以 FDA 處方資訊與同儕審查的試驗為依據。若要了解不變的基礎知識，請從我們的GLP-1 指南開始。
Microdosing GLP-1 in 2026
Microdosing GLP-1 medications is everywhere — but what does the evidence say? An honest look at what it means, why people do it, and what's known about safety.
Missed Your Wegovy Dose? (2026)
Missed a Wegovy shot? The '2-day' and '4-day' rules get confused online. Here's the FDA-label answer for Wegovy: when to take it late, and when to skip.
Oral GLP-1 Tracking in 2026
How the daily oral GLP-1 tablet schedule works, why the empty-stomach rule is non-negotiable, and what's worth tracking when your GLP-1 is a pill, not a shot.
Protein target on GLP-1 (g/kg), 2026 guide
How much protein should you aim for on a GLP-1? A source-backed look at targets in grams per kilogram, and how to hit the number when your appetite is low.
Semaglutide mg to Units (2026)
Converting a semaglutide dose from mg to insulin-syringe units? The answer depends on your vial's concentration — here's the arithmetic, and why charts are risky.
Zepbound Plateau at Week 12? (2026)
Stalled on Zepbound around week 12? Before assuming tirzepatide stopped working, check dose timing, steady state and titration stage — from the FDA label.
本內容為教育性質，並非醫療建議。每篇文章皆依據 FDA 處方資訊與引用的臨床試驗整理而成；請參閱我們的編輯政策，瞭解這些內容如何撰寫與更新。